Skip to content
lifestyle.rogueimc.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Anixa Biosciences, Inc.
Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040
September 21, 2026
Anixa Biosciences Appoints UPenn’s Dr. Carmen Guerra to Cancer Business Advisory Board
September 16, 2026
Anixa Biosciences Interview Highlighting Breast Cancer Vaccine to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
September 9, 2026
Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
September 3, 2026
Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy
August 24, 2026
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
August 19, 2026
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
August 19, 2026
Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
June 29, 2026
Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences’ Frontiers in Cancer Immunotherapy Symposium
June 26, 2026
Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences’ Frontiers in Cancer Immunotherapy Symposium
June 26, 2026
1
2
3
Next Page
→